Dr. Benjamin D. Ehst, M.D., PH.D.
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 80
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: University of Minnesota Medical School
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
OR license MD27612
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Broadway Medical Clinic LLP (18 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 80
- Services billed
- 323
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 99 | 17 |
| Established patient office or other outpatient visit, 20-29 minutes | 97 | 63 |
| Destruction of precancer skin growth, 1 growth | 41 | 26 |
| Established patient office or other outpatient visit, 30-39 minutes | 24 | 18 |
| Destruction of skin growth, 1-14 growths | 22 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clobetasol Propionate Other prescribers in Portland, OR | 27 |
| Skyrizi Pen (risankizumab-rzaa) | 17 |
| Methotrexate (methotrexate sodium) Other prescribers in Portland, OR | 15 |
| Bimzelx (bimekizumab-bkzx) | 13 |
| Triamcinolone Acetonide Other prescribers in Portland, OR | 12 |
| Acitretin | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 357 payments worth $243,325 in total to this clinician.
| Lilly USA, LLC | $89,303 |
|---|---|
| UCB, Inc. | $29,477 |
| Organon LLC | $26,695 |
| AbbVie Inc. | $25,198 |
| Regeneron Healthcare Solutions, Inc. | $17,162 |
| Novartis Pharmaceuticals Corporation | $13,978 |
| Leo Pharma Inc. | $12,784 |
| Leo Pharma As | $9,503 |
| Compensation for services other than consulting (speaking, faculty) | $155,730 |
|---|---|
| Consulting Fee | $57,130 |
| Travel and Lodging | $13,053 |
| Honoraria | $10,400 |
| Food and Beverage | $6,869 |
| Education | $142 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Organon LLC Feb 5, 2025 | Consulting Fee VTAMA · Dermatology | $12,450 |
| Leo Pharma As Oct 26, 2025 | Consulting Fee | $7,693 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $7,650 |
| Organon LLC Apr 2, 2025 | Honoraria VTAMA · Dermatology | $7,200 |
| UCB, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $7,000 |
| Leo Pharma Inc. Oct 2, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $5,763 |
| Genzyme Corporation Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,253 |
| Regeneron Healthcare Solutions, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,253 |
| AbbVie Inc. Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $5,250 |
| AbbVie Inc. Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $5,250 |
All 149 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Dec 26, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $2,075 |
| Leo Pharma Inc. Dec 23, 2025 | Compensation for services other than consulting (speaking, faculty) ANZUPGO · DERMATOLOGY | $905 |
| AbbVie Inc. Dec 19, 2025 | Consulting Fee RINVOQ · IMMUNOLOGY | $850 |
| UCB, Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $2,075 |
| Janssen Pharmaceuticals, Inc Dec 9, 2025 | Education TREMFYA · Immunology · in-kind | $13.17 |
| UCB, Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $2,075 |
| Incyte Corporation Dec 1, 2025 | Consulting Fee | $3,375 |
| Organon LLC Nov 25, 2025 | Honoraria VTAMA · Dermatology | $3,200 |
| Novartis Pharmaceuticals Corporation Nov 25, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Irving, TX · in-kind | $521 |
| Novartis Pharmaceuticals Corporation Nov 25, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Irving, TX · in-kind | $13.00 |
| AbbVie Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,250 |
| UCB, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $2,075 |
| Organon LLC Nov 20, 2025 | Travel and Lodging VTAMA · Dermatology · travel to San Francisco, CA · in-kind | $225 |
| Lilly USA, LLC Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Janssen Biotech, Inc. Nov 10, 2025 | Consulting Fee TREMFYA · Immunology | $3,400 |
| Lilly USA, LLC Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Novartis Pharmaceuticals Corporation Nov 7, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Irving, TX | $122 |
| Novartis Pharmaceuticals Corporation Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) Rhapsido · Immunology | $4,500 |
| AbbVie Inc. Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $4,250 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging travel to MEDFORD, OR · in-kind | $245 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging travel to MEDFORD, OR · in-kind | $230 |
| Regeneron Healthcare Solutions, Inc. Nov 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,388 |
| Leo Pharma As Oct 26, 2025 | Consulting Fee | $7,693 |
| Leo Pharma Inc. Oct 23, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $60.00 |
| Leo Pharma Inc. Oct 23, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $55.78 |
| Leo Pharma Inc. Oct 23, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $19.19 |
| Leo Pharma Inc. Oct 23, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $12.56 |
| Leo Pharma Inc. Oct 23, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $10.36 |
| Novartis Pharmaceuticals Corporation Oct 10, 2025 | Travel and Lodging Rhapsido · Immunology · travel to Irving, TX · in-kind | $196 |
| Leo Pharma Inc. Oct 2, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $5,763 |
| Leo Pharma Inc. Sep 8, 2025 | Consulting Fee | $2,725 |
| Leo Pharma Inc. Sep 6, 2025 | Travel and Lodging ANZUPGO · DERMATOLOGY · travel to ROSEMONT, IL · in-kind | $357 |
| Lilly USA, LLC Sep 4, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to SALEM, OR | $70.00 |
| Lilly USA, LLC Aug 22, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Aug 22, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| Incyte Corporation Aug 15, 2025 | Consulting Fee | $750 |
| Regeneron Healthcare Solutions, Inc. Aug 5, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to PORTLAND, OR · in-kind | $17.00 |
| Genzyme Corporation Jul 28, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $3,343 |
| Regeneron Healthcare Solutions, Inc. Jul 25, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,671 |
| Regeneron Healthcare Solutions, Inc. Jul 22, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $2,388 |
| Lilly USA, LLC Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Regeneron Healthcare Solutions, Inc. Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $4,059 |
| Leo Pharma As Jun 25, 2025 | Consulting Fee | $1,810 |
| Regeneron Healthcare Solutions, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,253 |
| Leo Pharma Inc. Jun 5, 2025 | Consulting Fee ADBRY · DERMATOLOGY | $1,302 |
| Regeneron Healthcare Solutions, Inc. Jun 5, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to DETROIT, MI · in-kind | $256 |
| Janssen Biotech, Inc. May 27, 2025 | Education TREMFYA · Immunology · in-kind | $99.99 |
| Lilly USA, LLC May 14, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC May 14, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| UCB, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $7,000 |
| Lilly USA, LLC May 8, 2025 | Consulting Fee EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $4,800 |
| UCB, Inc. May 8, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $4,500 |
| Lilly USA, LLC May 8, 2025 | Consulting Fee EBGLYSS · Immunology | $2,800 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $103 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $103 |
| Lilly USA, LLC May 8, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to DENVER, CO | $50.00 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $30.00 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $30.00 |
| Lilly USA, LLC May 8, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to DENVER, CO | $10.36 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $7.00 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $7.00 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $5.18 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $5.18 |
| UCB, Inc. May 8, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR | $2.00 |
| Lilly USA, LLC May 7, 2025 | Travel and Lodging travel to THE DALLES, OR · in-kind | $687 |
| Lilly USA, LLC May 6, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to PORTLAND, OR | $5.40 |
| Lilly USA, LLC May 6, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to PORTLAND, OR | $2.80 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Consulting Fee | $7,650 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ · in-kind | $30.00 |
| Novartis Pharmaceuticals Corporation May 2, 2025 | Travel and Lodging travel to EAST HANOVER, NJ | $10.36 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Travel and Lodging travel to Whippany, NJ · in-kind | $288 |
| Novartis Pharmaceuticals Corporation May 1, 2025 | Education in-kind | $19.31 |
| Organon LLC Apr 30, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Dallas, TX · in-kind | $60.00 |
| Organon LLC Apr 30, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Dallas, TX · in-kind | $10.36 |
| Lilly USA, LLC Apr 24, 2025 | Travel and Lodging travel to PHOENIX, CO · in-kind | $511 |
| Lilly USA, LLC Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| Regeneron Healthcare Solutions, Inc. Apr 17, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to DETROIT, MI · in-kind | $529 |
| UCB, Inc. Apr 17, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR · in-kind | $190 |
| UCB, Inc. Apr 16, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR · in-kind | $214 |
| UCB, Inc. Apr 16, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR · in-kind | $214 |
| UCB, Inc. Apr 16, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR · in-kind | $190 |
| Lilly USA, LLC Apr 15, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to SOLDOTNA, AK | $290 |
| Lilly USA, LLC Apr 15, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to SOLDOTNA, AK | $206 |
| Lilly USA, LLC Apr 15, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to SOLDOTNA, AK | $96.00 |
| Lilly USA, LLC Apr 15, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to SOLDOTNA, AK | $10.36 |
| Lilly USA, LLC Apr 11, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to WALLA WALLA, WA | $390 |
| UCB, Inc. Apr 5, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR · in-kind | $30.00 |
| UCB, Inc. Apr 5, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Medford, OR · in-kind | $30.00 |
| Organon LLC Apr 2, 2025 | Honoraria VTAMA · Dermatology | $7,200 |
| Organon LLC Apr 2, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Huntington Beach, CA · in-kind | $58.00 |
| Organon LLC Apr 2, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Huntington Beach, CA · in-kind | $10.36 |
| Lilly USA, LLC Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Organon LLC Mar 21, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Dallas, TX · in-kind | $809 |
| Organon LLC Mar 21, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Dallas, TX · in-kind | $313 |
| Organon LLC Mar 21, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Dallas, TX · in-kind | $210 |
| Lilly USA, LLC Mar 20, 2025 | Travel and Lodging travel to YAKIMA, WA · in-kind | $157 |
| Lilly USA, LLC Mar 18, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Mar 12, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to LAKE OSWEGO, OR | $15.40 |
| Lilly USA, LLC Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| Lilly USA, LLC Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| AbbVie Inc. Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $5,250 |
| AbbVie Inc. Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $5,250 |
| Leo Pharma Inc. Mar 5, 2025 | Consulting Fee | $905 |
| AbbVie Inc. Feb 28, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $137 |
| AbbVie Inc. Feb 28, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $60.00 |
| AbbVie Inc. Feb 28, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $5.18 |
| AbbVie Inc. Feb 28, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to BEND, OR · in-kind | $5.18 |
| Lilly USA, LLC Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Feb 20, 2025 | Travel and Lodging travel to SOLDOTNA, AK · in-kind | $925 |
| Lilly USA, LLC Feb 20, 2025 | Travel and Lodging travel to SOLDOTNA, AK · in-kind | $377 |
| Genzyme Corporation Feb 18, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,253 |
| Lilly USA, LLC Feb 14, 2025 | Travel and Lodging travel to HONOLULU, HI | $744 |
| Lilly USA, LLC Feb 14, 2025 | Travel and Lodging travel to HONOLULU, HI | $159 |
| Lilly USA, LLC Feb 14, 2025 | Travel and Lodging travel to HONOLULU, HI | $53.09 |
| Lilly USA, LLC Feb 14, 2025 | Travel and Lodging travel to HONOLULU, HI | $32.91 |
| Lilly USA, LLC Feb 14, 2025 | Travel and Lodging travel to HONOLULU, HI | $32.41 |
| UCB, Inc. Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $1,660 |
| Lilly USA, LLC Feb 13, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Organon LLC Feb 12, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Huntington Beach, CA · in-kind | $409 |
| Organon LLC Feb 12, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Huntington Beach, CA · in-kind | $305 |
| Organon LLC Feb 12, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Huntington Beach, CA · in-kind | $305 |
| Organon LLC Feb 12, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Costa Mesa, CA · in-kind | $277 |
| Organon LLC Feb 12, 2025 | Travel and Lodging VTAMA · Dermatology · travel to Huntington Beach, CA · in-kind | $210 |
| Lilly USA, LLC Feb 10, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| UCB, Inc. Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $4,500 |
| UCB, Inc. Feb 6, 2025 | Compensation for services other than consulting (speaking, faculty) Bimzelx · Immunology | $1,660 |
| UCB, Inc. Feb 6, 2025 | Travel and Lodging Bimzelx · Immunology · travel to Salem, OR · in-kind | $68.88 |
| Organon LLC Feb 5, 2025 | Consulting Fee VTAMA · Dermatology | $12,450 |
| AbbVie Inc. Jan 30, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to BEND, OR · in-kind | $491 |
| AbbVie Inc. Jan 30, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to BEND, OR · in-kind | $271 |
| Lilly USA, LLC Jan 21, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| AbbVie Inc. Jan 14, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,750 |
| AbbVie Inc. Jan 14, 2025 | Education in-kind | $9.65 |
| Lilly USA, LLC Jan 10, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jan 10, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| Incyte Corporation Jan 10, 2025 | Consulting Fee | $700 |
| Lilly USA, LLC Jan 10, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to LAKE OSWEGO, OR | $14.70 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 39 industry-funded studies in 2025, from 11 companies. The companies reported $2,116,991 in research payments for these studies, mostly to the institutions running them.
- Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
Eli Lilly and Company · Completed · NCT06588283 - A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo
Incyte Corporation - A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
Sanofi US Services Inc. · Active, not recruiting · NCT06407934 - A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASC…
Amgen Inc. - TAK-279-PsO-3003 A Phase 3, multi-center, open-label Study To Evaluate The Efficacy, Safety, And Tolerability of TAK-279 in Subjects With Moderate to Severe Plaque Psoriasis
Takeda Pharmaceuticals U.S.A., Inc. - A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata
Sanofi US Services Inc. · Terminated · NCT06444451 - A study about how well TAK-279 works and its safety in participants with moderate-to-severe plaque psoriasis during 60 weeks of treatment with a withdrawal and retreatment period
Takeda Pharmaceuticals U.S.A., Inc. - A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Mod…
Janssen Research & Development, LLC - A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Incyte Corporation - A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants with Moderate to Severe Plaque Psoriasis with Randomized …
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.